Skip to main content
SpringerLink
Log in

Alternative Approaches

  • Chapter
Clinical Pharmacology in Psychiatry

  • 166 Accesses

Abstract

Why do we measure plasma concentrations? If we can answer this question clearly, the validity and feasibility of attaining that goal by other means can be evaluated. The practical value of measuring plasma concentrations is to optimize treatment, to attain the best balance in each particular patient between wanted clinical therapeutic effects and unwanted adverse and side effects (Richens and Warrington, 1979).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bond, A. J., James, D. C. and Lader, M. H. (1974). Sedative effects on physiological and psychological measures in anxious patients. Psychol. Med., 4, 374–80

    Article  PubMed  CAS  Google Scholar 

  • Brown, W. A. (1977). Psychologic and neuroendocrine response to methylphenidate. Archs gen. Psychiat., 34, 1103–8

    Article  CAS  Google Scholar 

  • Bye, C. E., Clubley, M., Henson, T., Peck, A. W., Smith, S. A. and Smith S. E. (1979). Changes in the human light reflex as a measure of the anticholinergic effects of drugs. A comparison with other measures. Eur. J. clin. Pharmac., 15, 21–5

    Article  CAS  Google Scholar 

  • Checkley, S. A. (1980). Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol. Med., 10, 35–53

    Article  PubMed  CAS  Google Scholar 

  • Coppen, A., Ghose, K., Swade, C. and Wood, K. (1978). Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man. Br. J. clin. Pharmac., 5, 13S–17S

    Article  CAS  Google Scholar 

  • Gruen, P. H., Sachar, E. J., Langer, G., Altman, N., Leifer, M., Frantz, A. and Halpern, F. S. (1978). Prolactin responses to neuroleptics in normal and schizophrenic subjects. Archs gen. Psychiat., 35, 108–16

    Article  CAS  Google Scholar 

  • Lader, M. (1976). Monitoring plasma concentrations of neuroleptics. Pharmako-psychiatrie, 4, 160–77

    Google Scholar 

  • Lin, K. M. and Friedel, R. O. (1979). Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response. Am. J. Psychiat., 136, 18–23

    Article  PubMed  CAS  Google Scholar 

  • Marshall, E. K. (1940). Experimental basis of chemotherapy in the treatment of bacterial infections. Bull. N.Y. Acad. Med., 16, 722–31

    Google Scholar 

  • Mindham, R. H. S., Howland, C. and Shepherd, M. (1973). An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol. Med., 3, 5–17

    Article  PubMed  CAS  Google Scholar 

  • Nikitopoulu, G., Thorner, M., Crammer, J. and Lader, M. (1977). Prolactin and psychophysiologic measures after single doses of thioridazine. Clin. Pharmac. Ther., 21, 422–9

    Google Scholar 

  • Richens, A. and Warrington, S. (1979). When should plasma drug levels be monitored? Drugs, 17, 488–500

    Article  PubMed  CAS  Google Scholar 

  • Risch, S. C., Huey, L. Y. and Janowsky, D. S. (1979). Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature. J. clin. Psychiat., 40, 4–16

    Google Scholar 

  • Robinson, D. S., Nies, A., Ravaris, C. L., Ives, J. O. and Bartlett, D. (1978). Clinical pharmacology of phenelzine. Archs gen. Psychiat., 35, 629–35

    Article  CAS  Google Scholar 

  • Shannon, J. A. (1946). The study of antimalarials and antimalarial activity in the human malarias. Harvey Lect. Ser., 41, 43–89

    CAS  Google Scholar 

  • Tyrer, P., Gardner, M., Lambourn, J. and Whitford, M. (1980). Clinical and pharmacokinetic factors affecting response to phenelzine. Br. J. Psychiat., 136, 359–65

    Article  CAS  Google Scholar 

  • Vaughn, C. E. and Leff, J. P. (1976). The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. Br. J. Psychiat., 129, 125–37

    Article  CAS  Google Scholar 

  • Yesavage, J. A., Tinklenberg, J. R., Hollister, L. E. and Berger, P. A. (1979). Vasodilators in cerebral dementias. A review of the literature. Archs gen. Psychiat., 36, 220–3

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Psychopharmacology, Institute of Psychiatry, University of London, London, UK

    Malcolm Lader

Authors
  1. Malcolm Lader
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institute of Mental Health, Parklawn Building, Room 9C-09, 5600 Fishers Lane, Rockville, Maryland, 20857, USA

    Earl Usdin

  2. Department of Pharmacology, Institute of Medical Biology, University of Tromsø, N-9000, Tromsø, Norway

    Svein G. Dahl

  3. Department of Pharmacology, Odense University, J. B. Winslöwsvej 19, DK-5000, Odense C, Denmark

    Lars F. Gram

  4. Department of Clinical Psychiatry, Institute of Community Medicine, University of Tromsø, N-9000, Tromsø, Norway

    Odd Lingjærde

Copyright information

© 1981 The contributors

About this chapter

Cite this chapter

Lader, M. (1981). Alternative Approaches. In: Usdin, E., Dahl, S.G., Gram, L.F., Lingjærde, O. (eds) Clinical Pharmacology in Psychiatry. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05929-4_2

Download citation

Publish with us

Policies and ethics

Search

Navigation